Project Grant R43OH012414

This $255,966 National Science Foundation Technology, Innovation, and Partnerships award to Nano-Product Engineering, LLC will support the development of an antiviral/antimicrobial micropowder for application to personal protective equipment and respiratory equipment surfaces. The award period is from September 15, 2022 through May 31, 2023. The project aims to improve the protective properties of commonly used PPE and respiratory equipment, which typically only provides passive protection and...

The National Science Foundation (NSF) awarded a $878,296 Cooperative Agreement to Surfplasma Inc., a minority-owned small business based in Gainesville, FL, to develop a rapid, low-temperature plasma prototype for disinfecting personal protective equipment (PPE), medical devices, food products and other materials from pathogens like COVID-19. The project, funded under NSF's Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to deliver a market-ready sterilization solution...

The National Institute of Standards and Technology awarded Vuronyx Technologies LLC a $1,599,940.60 cooperative agreement under the Science, Technology, Business and/or Education Outreach program (CFDA 11.620) to develop acetylperoxyborate (APB) powders for disinfecting personal protective equipment. Vuronyx will perform efficacy testing of APB powders against viruses on test coupons and evaluate resulting byproducts and residues. It will also evaluate the structural integrity of N95 masks and...

This $249,999 National Science Foundation project grant supports the development of a bioengineered nanobarrier spray to protect against SARS-CoV-2 and other viral infections of the nasopharynx. Funded under the NSF Engineering program (CFDA 47.041), the two-year award to the University of Southern California will support computational modeling of nanobarrier delivery via nasal applicator as well as efficacy testing in a coronavirus mouse model. Specifically, the university researchers will...

The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to Avior Inc., doing business as Avior Bio, to develop a safe and effective copper nanoparticle suspension formulation for face mask applications against SARS-CoV-2 and other viruses. The grant period runs from July 1, 2021 through December 31, 2021 under the Engineering (47.041) federal grant program. Through this funding, Avior Bio will work to produce a nanoparticle formulation that can be...

Fathhome, Inc. received a $255,999 Project Grant award from the National Science Foundation on February 15, 2021 to develop an ozone-based field sterilizer for rapid sterilization and reuse of N95 respirators and other personal protective equipment in response to the COVID-19 pandemic. The work is being conducted under the NSF's Technology, Innovation, and Partnerships program (CFDA 47.084), which seeks to advance science and engineering research and innovative solutions to national...

The National Science Foundation awarded a $255,961 Small Business Technology Transfer Phase I Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to Rush River Research Corp. The grant aims to develop a low-cost, automated receptacle for rapid point-of-care sterilization of personal protective equipment, such as filtering facepiece respirators, for frontline healthcare workers during the COVID-19 pandemic. Specifically, the company will construct and...

This $788,406 project grant from the National Institutes of Health National Institute of Allergy and Infectious Diseases, under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund the development of a sensitive, direct reading bioaerosol detection platform to quantify airborne pathogens such as SARS-CoV-2. Aerosol Devices Inc. will integrate their gentle condensation-growth capture sampler, which concentrates intact, viable virus particles into a small liquid volume...

This $593,860 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund the development of phage-polymer nanoparticle conjugates to treat antibiotic-resistant wound biofilm infections. The key products and services to be delivered under this grant include: Synthesis of novel homo- and block copolymers to be non-covalently conjugated with phages effective against...

This $255,982 National Science Foundation project grant supports the development of sustainable, cost-effective viral clearance membranes by Filtravate, Inc. to enable efficient monoclonal antibody processing. The NSF Technology, Innovation, and Partnerships program seeks technologies leading to breakthrough solutions for national challenges. Specifically, Filtravate will develop a virus filtration membrane using a synthesis process that is more sustainable and affordable than conventional...